Maeda, Akimitsu http://orcid.org/0000-0002-0709-3911
Ando, Hitoshi http://orcid.org/0000-0001-6179-9993
Irie, Kei http://orcid.org/0000-0002-0820-1208
Hashimoto, Naoya
Morishige, Jun-ichi
Fukushima, Shoji
Okada, Akira
Ebi, Hiromichi http://orcid.org/0000-0003-3155-7576
Matsuzaki, Masahide
Iwata, Hiroji
Sawaki, Masataka
Funding for this research was provided by:
Aichi Cancer Research Foundation
Article History
Received: 17 January 2022
Accepted: 2 May 2022
First Online: 9 May 2022
Declarations
:
: All procedures performed in this study that involved human participants were conducted in accordance with the standards of the Ethics Committee of Aichi Cancer Center Hospital (No.: 2018–2-27) and the Declaration of Helsinki.
: Written informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Hitoshi Ando had received a grant from Eli Lilly Japan. Hiroji Iwata had received honorarium for educational lectures and advisor from Eli Lilly Japan. All other authors declare no competing interests.